InvestorsHub Logo
Followers 12
Posts 616
Boards Moderated 0
Alias Born 05/06/2016

Re: None

Wednesday, 05/11/2016 4:25:36 PM

Wednesday, May 11, 2016 4:25:36 PM

Post# of 232924
Dr. Nader addressed the concern that investors are having with the competition of ibalizumab. The drug is in phase III clinical trials for intramuscular TERMINAL patients (very small market). TaiMed (maker of ibalizumab) is currently doing clinical trials for subcutaneous, but they are only in phase I.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News